No, there has been more research since January, which the article itself said was needed. — Xtrix
Until you realize that this article was last updated 8 months ago, and is originally from January. — Xtrix
The fact that the companies aren’t trying to cover up their own fuckup. — Michael
The fact that since the introduction of the vaccines the number of deaths, serious symptoms, and cases has dropped. — Michael
The fact that there have been very few negative reactions to the vaccines. — Michael
I know this is a tough one, but think about it for a second. — Xtrix
Scientists do not yet know whether COVID-19 vaccinations will reduce transmission because this was not tested in the trials (here, here). Instead, they found candidate vaccines were able to prevent symptomatic and severe effects of COVID-19 (here), meaning future research would need to take this further (here). For instance, it would need to look deeper into how the vaccine works in the body – whether it prevents an individual getting infected altogether, or whether it simply stops a person becoming sick. With the latter, this could mean the virus continues to replicate in the nose and throat, and is still able to spread (here). — https://www.reuters.com/article/uk-factcheck-transmission-idUSKBN29N1UH
However, it is the place where you find me. — Metaphysician Undercover
andThat's just the old problem of trying to identify some thing that corresponds to the word. Obviously, not all words function like that, and sensation, is just one such word. — Sam26
We quickly learn what the word does. That doesn't require us to refer to any private 'sensation' at all. — Isaac
it's use (and associated conceptual responses) is a strategy to get something done within a social context. It might be the wrong strategy, it might not do what we expect it to do (same as any other response). In that case we've used the wrong model, we made a mistake reaching for the word "pain". — Isaac
So you believe that the vaccine is either more dangerous than the disease or ineffective? It’s neither. So this reasoning is fallacious. — Michael
There’s enough to go around. I don’t know about wherever you live but the UK has ordered enough for every adult, and presumably some children too. — Michael
I can’t see anything like that for choosing to not be vaccinated. — Michael
I don't trust the pharmaceutical industry and I don't agree that giving vaccines to healthy people who have little chance of contracting the severe disease is a good use of limited resources. — Isaac
Getting vaccinated is such a minor inconvenience that requires no lifestyle changes — Michael
Ya, but when you say things like this, — Sam26
If you were vaccinated you would be even less likely to get infected and transmit the virus. — Janus
You haven't given any good reason why you shouldn't be vaccinated, and nor have you explained why you don't want to be vaccinated. — Janus
I don't trust the pharmaceutical industry and I don't agree that giving vaccines to healthy people who have little chance of contracting the severe disease is a good use of limited resources. — Isaac
And I said you couldn't possibly know what the death toll would have been or will be twenty years into the future. But you ignored those qualifications regarding the future. — Janus
Do you have any papers to cite in support of that claim? That may indeed be the more likely scenario, but who knows? Even the experts can't predict the future with certainty. — Janus
Other social issues should be addressed of course, but the emergency now is the fight against covid. — Janus
I think you are going against the grain of expert opinion if you think that vaccination is a "small part". The consensus seems to be that without vaccines we might never get out of the next wave/ lockdown cycle — Janus
You still haven't given your reasons for not wanting the vaccine. Do you have a rational reason or are you simply afraid of it? — Janus
all aspects of most high impact, industry-sponsored clinical trials remain influenced by industry and systematically produce more favourable efficacy findings and conclusions than research supported by other sources — Lundh A, Lexchin J, Mintzes B, et al.Industry sponsorship and research outcome. Cochrane Database Syst Rev
85% of vaccine clinical trials are sponsored by vaccine manufacturers and non-industry trials are over four times more likely to report negative or mixed findings than industry-sponsored trials — Manzoli L, Flacco ME, D’Addario M, et al. Non-publication and delayed publication of randomized trials on vaccines: survey. BMJ
the majority of panel members producing clinical practice guidelines have disclosed or undisclosed financial CoI [Conflicts of Interest] — Neuman J, Korenstein D, Ross JS, et al.Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ
On June 7, the FDA approved aducanumab for the treatment of Alzheimer's disease. The drug received accelerated approval because it showed it could reduce the rate of amyloid plaque on scans. What remains uncertain is whether this reduction in plaque means Alzheimer's patients live longer or better lives -- and notably, the totality of the clinical trial data do not show that. Moreover, the drug has various side effects and a whopping price tag: $56,000 a year.
In response to the FDA's approval, three members of the Peripheral and Central Nervous System Drugs Advisory Committee who opposed approval of the drug, quit the panel in protest. Aaron Kesselheim, MD, JD, MPH, a Harvard professor called the drug "problematic," and argued that there was little evidence it would help patients. Writing in The Atlantic, Nicholas Bagley, JD, and Rachel Sacks, JD, MPH, estimate that if the drug is prescribed to just one-third of eligible patients, it would cost Medicare $112 billion a year -- a massive figure that dwarfs any other medication.
On 28 July 2021, Pfizer and BioNTech posted updated results for their ongoing phase 3 covid-19 vaccine trial. The preprint came almost a year to the day after the historical trial commenced, and nearly four months since the companies announced vaccine efficacy estimates “up to six months.”
measuring vaccine efficacy two months after dosing says little about just how long vaccine-induced immunity will last. “We’re going to be looking very intently at the durability of protection,” Pfizer senior vice president William Gruber, an author on the recent preprint, told the FDA’s advisory committee last December.
But you won’t find 10 month follow-up data here. While the preprint is new, the results it contains aren’t particularly up to date. In fact, the paper is based on the same data cut-off date (13 March 2021) as the 1 April press release, and its topline efficacy result is identical: 91.3% (95% CI 89.0 to 93.2) vaccine efficacy against symptomatic covid-19 through “up to six months of follow-up.”
As an RCT reporting “up to six months of follow-up,” it is notable that evidence of waning immunity was already visible in the data by the 13 March 2021 data cut-off.
“From its peak post-dose 2,” the study authors write, “observed VE [vaccine efficacy] declined.” From 96% to 90% (from two months to <4 months), then to 84% (95% CI 75 to 90) “from four months to the data cut-off,” which, by my calculation (see footnote at the end of the piece), was about one month later.
But although this additional information was available to Pfizer in April, it was not published until the end of July.
The final efficacy timepoint reported in Pfizer’s preprint is “from four months to the data cut-off.” The confidence interval here is wider than earlier time points because only half of trial participants (53%) made it to the four month mark, and mean follow-up is around 4.4 months
Despite the reference to “six month safety and efficacy” in the preprint’s title, the paper only reports on vaccine efficacy “up to six months,” but not from six months. This is not semantics, as it turns out only 7% of trial participants actually reached six months of blinded follow-up (“8% of BNT162b2 recipients and 6% of placebo recipients had ≥6 months follow-up post-dose 2.”) So despite this preprint appearing a year after the trial began, it provides no data on vaccine efficacy past six months, which is the period Israel says vaccine efficacy has dropped to 39%.
Former FDA commissioner Scott Gottlieb, who is on Pfizer’s board [[b]says it all doesn't it? - my addition[/b]], said: “Remember, the original premise behind these vaccines were [sic] that they would substantially reduce the risk of death and severe disease and hospitalization. And that was the data that came out of the initial clinical trials.”
Yet, the trials were not designed to study severe disease. In the data that supported Pfizer’s EUA, the company itself characterized the “severe covid-19” endpoint results as “preliminary evidence.” Hospital admission numbers were not reported, and zero covid-19 deaths occurred.
In the preprint, high efficacy against “severe covid-19” is reported based on all follow-up time (one event in the vaccinated group vs 30 in placebo), but the number of hospital admissions is not reported so we don’t know which, if any, of these patients were ill enough to require hospital treatment. (In Moderna’s trial, data last year showed that 21 of 30 “severe covid-19” cases were not admitted to hospital; Table S14).
on preventing death from covid-19, there are too few data to draw conclusions—a total of three covid-19 related deaths (one on vaccine, two on placebo). There were 29 total deaths during blinded follow-up (15 in the vaccine arm; 14 in placebo).
“GILD is a case in point, where the success of its hepatitis C franchise has gradually exhausted the available pool of treatable patients,” the analyst wrote. “In the case of infectious diseases such as hepatitis C, curing existing patients also decreases the number of carriers able to transmit the virus to new patients, thus the incident pool also declines … Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise.”
the number of children on medication for ADHD has grown to 3.5 million from 600,000 in 1990, according to the Centers for Disease Control and Prevention. A diagnosis is now found in 15 percent of high-school age children when, in fact, the true rate is closer to 5 percent, with only a small minority of that group truly needing to be medicated.
This gross over-diagnosis and prescription is a direct result of intense, multi-million dollar marketing campaigns by the drug makers, both through celebrity endorsements as well print and television ads that prompt patients and their families to ask doctors about those specific drugs. The result is to sway doctors to go for the easy, quick fix solution of a pill (when you have a hammer, everything you see is a nail). And the tactic has paid off, with a quintupling of stimulant sales since 2002, to over $8 billion in revenues.
The practice has created a situation of widespread drug abuse, affecting the long-term health and well-being of millions of young people. This mess has prompted long-time ADHD advocate Dr. Keith Conners to call the rising diagnosis rates a “concoction to justify the giving out of medication at unprecedented and unjustifiable levels,” that has resulted in “a national disaster of dangerous proportions.” — New York Times - The Rise in Ritalin
I'm not sure what you're getting at here. — frank
if the effort had not been put in the death toll would likely have been much. much greater by now and into the near future. — Janus
You don't know how great the death toll could be in twenty years; it's pure conjecture. — Janus
If there were no vaccination program much more virulent strains might have emerged. They might anyway. — Janus
I am really struggling to see what your position actually is. Are you against the vaccination program? Do you think there is a viable alternative to it in the situation we find ourselves in? — Janus
Some of this stuff would require a global government. — frank
it seems to me that Isaac is really adding a new language-game to the mix based on new information. It could be that the example (not sure at this point) of pain and doubting that one is in pain, is generally senseless, but that there are exceptions. — Sam26
So ↪Isaac
presents an example of someone doubting the applicability of the word "pain" to their present situation. That's not the same as doubting that one is in pain. — Banno
Why are you doubting that you or someone else is using the word "pain" correctly? — Luke
I don't see how the word could be used (in the sense we are using it here) without reference to the sensation. Pain is a sensation. — Luke
Decades later, people wish they had addressed the weaknesses of those health systems, because new threats keep coming. — Olivier5
The more efficient method is to let them die in their front yards gasping for breath? Or what? — frank
National leaders and leaders of international organizations and other stakeholders take early decisive action based on science, evidence and best practice when confronted with health emergencies. They discourage the politicization of measures to protect public health, ensure social protection and promote national unity and global solidarity.
We reiterate our call for heads of government to appoint a national high-level coordinator with the authority and political accountability to lead whole-of government and whole-of-society approaches, and routinely conduct multisectoral simulation exercises to establish and maintain effective preparedness.
National leaders, manufacturers and international organizations ensure that COVID-19 vaccines and other countermeasures are allocated in a way that will have the most impact in stopping the pandemic, that access is fair and equitable, and not based on ability to pay, with health care workers and the most vulnerable having priority access. Each country should get an initial allocation of vaccine sufficient to cover at least 2% of its population, to cover frontline health care workers.
Citizens demand accountability from their governments for health emergency preparedness, which requires that governments empower their citizens and strengthen civil society.
Every individual takes responsibility for seeking and using accurate information to educate themselves, their families and their communities. They adopt health promoting behaviours and take actions to protect the most vulnerable. They advocate for these actions within their communities.
Heads of government strengthen national systems for preparedness: identifying, predicting and detecting the emergence of pathogens with pandemic potential based on a ‘One Health’ approach that integrates animal and human health; building core public health capacities and workforce for surveillance, early detection and sharing of information on outbreaks and similar events; strengthening health systems based on universal health coverage with surge capacity for clinical and supportive services; and putting in place systems of social protection to safeguard the vulnerable, leaving no one behind.
Researchers, research institutions, research funders, the private sector, governments, the World Health Organization and international organizations improve coordination and support for research and development in health emergencies and establish a sustainable mechanism to ensure rapid development, early availability, effective and equitable access to novel vaccines, therapeutics, diagnostics and non-pharmaceutical interventions for health emergencies, including capacity for testing, scaled manufacturing and distribution.
Heads of government renew their commitment to the multilateral system and strengthen WHO as an impartial and independent international organization, responsible for directing and coordinating pandemic preparedness and response.
We call for sustained investment in prevention and preparedness, commensurate with the scale of a pandemic threat.
G20 leaders ensure that adequate finance is made available now to mitigate the current and future economic and socioeconomic consequences of the pandemic.
Heads of government protect and sustain the financing of their national capacities for health emergency preparedness and response developed for COVID-19, beyond the current pandemic.
The United Nations, the World Health Organization, and the International Financing Institutions develop a mechanism for sustainable financing of global health security, which mobilizes resources on the scale and within the timeframe required, is not reliant on development assistance, recognizes preparedness as a global common good, and is not at the mercy of political and economic cycles.
The World Bank and other International Financial Institutions (IFI) make research and development (R&D) investments eligible for IFI financing and develop mechanisms to provide financing for global R&D for health emergencies.
State Parties to the International Health Regulations (IHR), or the WHO Director-General, propose amendments of the IHR to the World Health Assembly, to include: strengthening early notification and comprehensive information sharing; intermediate grading of health emergencies; development of evidence based recommendations on the role of domestic and international travel and trade recommendations; and mechanisms for assessing IHR compliance and core capacity implementation, including a universal, periodic, objective and external review mechanism.
National leaders, the World Health Organization, the United Nations and other international organizations develop predictive mechanisms for assessing multisectoral preparedness, including simulations and exercises that test and demonstrate the capacity and agility of health emergency preparedness systems, and their functioning within societies.
The Secretary-General of the United Nations, the Director-General of the World Health Organization, and the heads of International Financing Institutions convene a UN Summit on Global Health Security, with the aim of agreeing on an international framework for health emergency preparedness and response, incorporating the IHR, and including mechanisms for sustainable financing, research and development, social protection, equitable access to countermeasures for all, and mutual accountability. — WHO-Global Preparedness Monitoring Board
Although, the investment in this vaccine technology will ultimately save lives in the future because it will speed up response to the next asshole virus. — frank
So we are making progress? — Olivier5
well funded. — Olivier5
Just to make the observation note that this isn't just your average flu epidemic. — ssu
Every other epidemic (pandemic) has had far less deaths with (with the exception of HIV). — ssu
No, I'm talking about the first-person, doubting that they are using the word "pain" correctly — Isaac
First-person is you, not they. — Luke
Someone that doesn't know or understand that there are far more Americans today than one hundred years ago has to go to himself or herself. It isn't misleading. — ssu
You're failing to take into account the fact that the figure would likely be much higher if "social, economic and political effort" hadn't been "put to reducing" it. — Janus
we took no further steps at all — Isaac
You're now talking in terms of third-person modelling — Luke
Wittgenstein says that it is possible for other people to doubt whether I'm in pain. But if you're the one who is obviously hurting, then doubt is misplaced. There is no hypothesis to be tested or knowledge to be gained from the perspective of the one who's in pain. — Luke
Maybe the "unpleasant sensation" of pain covers a wide range of sensations that causes some difficulties for scientists, but we all quickly learn what the word means. — Luke
I have an image of someone groaning in agony as the doctor says "no, no, she's not in pain...look at the signals we are getting..." — Banno
I want to add
d) a sensation that is not private. — Banno
You started that post talking about the sensation of pain as a natural kind, but then you went on to talk about constructing models in terms of expressions of pain. — Luke
if the abstract to your primer is anything to go by, then it discusses emotions, not sensations. — Luke
Of course there are more Americans now than then. — ssu
Absolute global poverty has gone down. But that naturally isn't the politically correct news to say. Especially for Americans. — ssu
Yes, but not with my recent questioning of your implication that there are no natural expressions or reactions. — Luke
I don't see what conscious processing and language use have to do with natural reactions/expressions. — Luke
Explain to me how your autonomous reactions are different from natural reactions/expressions and maybe I'll read it. — Luke
I was only talking about natural expressions/reactions, not language. — Luke
How are you distinguishing those autonomous responses (such as "already pulled aware from the hot thing, or shielded the pain site") from natural expression/reactions? — Luke
Your account of why we don't actually say "I wasn't in pain, I was just cold and cross" is because we believe in natural kinds, not because there are natural kinds. I don't see how that's an account rather than an assertion. We might believe in natural kinds because there are natural kinds. — Luke
You're implying that there are no natural human expressions or reactions. How are a tendency to say "ouch" or a tendency to withdraw from the perceived source [of pain] not natural expressions or reactions, but merely "something we construct"? Don't most animals tend to withdraw from perceived sources of pain? — Luke
Such general facts of nature (PI 142) are pivotal to Wittgenstein's work — Luke
there's very strong evidence to support it. Why else do you think we don't actually say "I wasn't in pain, I was just cold and cross"? — Luke
I think we addressed this long ago, but we might have a clearer example here. — Banno
If it is totally inconsequential to the problem at hand, why did you bring up "holding the government into account"? — Olivier5
That such a sentiment be justified in Congo doesn't make it justified where I live — Olivier5
I just meant that science doesn't really offer soapboxes to preach from. People make science into a church to back their misanthropy or what have you. — frank
they shared the guilt of the Mobutu regime, because they had done nothing to oppose it. — Olivier5
You can do that and still take your shot. — Olivier5
That's not what I am trying to do. As I explained, I am trying NOT TO UNDERMINE trust. I'm not trying to actively shore it up, but I don't want to contribute to its fall. — Olivier5
